Obesity as a modifiable risk factor for hypertrophic cardiomyopathy.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Adalsteinsdottir, BerglindIssue Date
2020-01-13
Metadata
Show full item recordCitation
Adalsteinsdottir B. Obesity as a modifiable risk factor for hypertrophic cardiomyopathy [published online ahead of print, 2020 Jan 13]. Eur J Prev Cardiol. 2020;2047487319897164. doi:10.1177/2047487319897164Description
To access publisher's full text version of this article click on the hyperlink belowAdditional Links
https://journals.sagepub.com/doi/10.1177/2047487319897164ae974a485f413a2113503eed53cd6c53
10.1177/2047487319897164
Scopus Count
Collections
Related articles
- Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy.
- Authors: Garfinkel AC, Seidman JG, Seidman CE
- Issue date: 2018 Apr
- Higher Body Mass Index in Adolescence Predicts Cardiomyopathy Risk in Midlife.
- Authors: Robertson J, Schaufelberger M, Lindgren M, Adiels M, Schiöler L, Torén K, McMurray J, Sattar N, Åberg M, Rosengren A
- Issue date: 2019 Jul 9
- Obesity is associated with worse long-term outcomes in hypertrophic cardiomyopathy patients with acute myocardial infarction.
- Authors: Yang J, Wang L, Sun T, Guo Q, Liu F, Zhou Y
- Issue date: 2020 Jul
- Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy.
- Authors: Park JB, Kim DH, Lee H, Hwang IC, Yoon YE, Park HE, Choi SY, Kim YJ, Cho GY, Han K, Ommen SR, Kim HK
- Issue date: 2020 Nov
- Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy.
- Authors: Heitner SB, Fischer KL
- Issue date: 2019 Feb